Andrew D. Cherniack
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Polyomavirus and related diseases
Strong evidence · 1 supporting paper · latest 2026
Neuroblastoma Research and Treatments
Strong evidence · 1 supporting paper · latest 2026
Advanced Breast Cancer Therapies
Solid evidence · 3 supporting papers · latest 2026
HER2/EGFR in Cancer Research
Solid evidence · 3 supporting papers · latest 2026
Cancer Genomics and Diagnostics
Solid evidence · 2 supporting papers · latest 2026
Breast Cancer Treatment Studies
Solid evidence · 2 supporting papers · latest 2026
Cancer Cells and Metastasis
Solid evidence · 1 supporting paper · latest 2026
Cancer Treatment and Pharmacology
Solid evidence · 1 supporting paper · latest 2026
Publications (7)
Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models
2026DOIPMID 42383359
Genomic markers of resistance to first-line (1L) therapy with a CDK4/6 inhibitor (CDKi) and endocrine therapy (ET) in patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (MBC).
2026DOI
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
2026DOIPMID 41826432
Clinical impact of panel-based next-generation sequencing in a real-world cohort of neuroblastoma patients.
2026DOI
A compendium of next-generation patient-derived models for diverse cancers
2026DOI
Tumor genomics in patients younger than 40 years of age with metastatic breast cancer
2026DOIPMID 41748861
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
2026DOIPMID 42140950
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
- Dana-Farber Cancer Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27